These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30621913)

  • 1. Malaria vaccine trials in pregnant women: An imperative without precedent.
    Healy SA; Fried M; Richie T; Bok K; Little M; August A; Riley L; Swamy GK; Wylie BJ; Menendez C; Muehlenbachs A; Doumbo O; Greenwood B; Billingsley PF; Hoffman SL; Duffy PE
    Vaccine; 2019 Feb; 37(6):763-770. PubMed ID: 30621913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
    Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
    Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Differential Antibody and T-Cell Responses to the
    Jongo SA; Church LWP; Mtoro AT; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Gondwe L; Studer F; Fink M; Cosi G; El-Khorazaty J; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2019 Jun; 100(6):1433-1444. PubMed ID: 30994090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.
    Hoffman SL; Billingsley PF; James E; Richman A; Loyevsky M; Li T; Chakravarty S; Gunasekera A; Chattopadhyay R; Li M; Stafford R; Ahumada A; Epstein JE; Sedegah M; Reyes S; Richie TL; Lyke KE; Edelman R; Laurens MB; Plowe CV; Sim BK
    Hum Vaccin; 2010 Jan; 6(1):97-106. PubMed ID: 19946222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
    Mo AX; Pesce J; Hall BF
    Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa.
    Billingsley PF; Maas CD; Olotu A; Schwabe C; García GA; Rivas MR; Hergott DEB; Daubenberger C; Saverino E; Chaouch A; Embon O; Chemba M; Nyakarungu E; Hamad A; Cortes C; Schindler T; Mpina M; Mtoro A; Sim BKL; Richie TL; McGhee K; Tanner M; Obiang Lima GM; Abdulla S; Hoffman SL; Ayekaba MO
    Am J Trop Med Hyg; 2020 Sep; 103(3):947-954. PubMed ID: 32458790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
    Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
    J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
    Mahmoudi S; Keshavarz H
    Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of whole sporozoite malaria vaccines.
    Hollingdale MR; Sedegah M
    Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.
    Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B
    Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016.
    Roestenberg M; Mordmüller B; Ockenhouse C; Mo A; Yazdanbakhsh M; Kremsner PG
    Vaccine; 2017 Dec; 35(51):7065-7069. PubMed ID: 29153778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
    Jongo SA; Church LWP; Mtoro AT; Schindler T; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Fink M; Cosi G; Gondwe L; Studer F; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
    Clin Infect Dis; 2020 Dec; 71(11):2849-2857. PubMed ID: 31782768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
    Laurens MB; Kouriba B; Bergmann-Leitner E; Angov E; Coulibaly D; Diarra I; Daou M; Niangaly A; Blackwelder WC; Wu Y; Cohen J; Ballou WR; Vekemans J; Lanar DE; Dutta S; Diggs C; Soisson L; Heppner DG; Doumbo OK; Plowe CV; Thera MA
    PLoS One; 2017; 12(3):e0173294. PubMed ID: 28282396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The malaria vaccine--status quo 2013.
    Heppner DG
    Travel Med Infect Dis; 2013; 11(1):2-7. PubMed ID: 23454205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of
    James ER; Matheny S; Overby J; Sim BKL; Eappen AG; Li T; Li ML; Richie TL; Chakravarty S; Gunasekera A; Murshedkar T; Billingsley PF; Hoffman SL
    Front Immunol; 2022; 13():851028. PubMed ID: 35242146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report.
    Menéndez C; Moorthy VS; Reed Z; Bardají A; Alonso P; Brown GV
    Expert Rev Vaccines; 2011 Sep; 10(9):1271-80. PubMed ID: 21919617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.
    Luke TC; Hoffman SL
    J Exp Biol; 2003 Nov; 206(Pt 21):3803-8. PubMed ID: 14506215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.